Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019
- PMID: 38265170
- PMCID: PMC11060160
- DOI: 10.1111/jdi.14146
Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019
Abstract
Aims: This study assessed diabetes (type 1 and type 2) mortality in China and globally from 1990 to 2019, predicting the next decade's trends.
Materials and methods: Data came from the Global Burden of Disease (GBD) database. The annual percentage change (AAPC) in age-standardized mortality rates (ASMR) for diabetes (type 1 and type 2) during 1990-2019 was calculated. A Bayesian age-period-cohort (BAPC) model predicted diabetes (type 1 and type 2) mortality from 2020 to 2030.
Results: In China, type 1 diabetes deaths declined from 6,005 to 4,504 cases (AAPC -2.827), while type 2 diabetes deaths rose from 64,084 to 168,388 cases (AAPC -0.763) from 1990 to 2019. Globally, type 1 diabetes deaths increased from 55,417 to 78,236 cases (AAPC 0.223), and type 2 diabetes deaths increased from 606,407 to 1,472,934 cases (AAPC 0.365). Both China and global trends showed declining type 1 diabetes ASMR. However, female type 2 diabetes ASMR in China initially increased and then decreased, while males had a rebound trend. Peak type 1 diabetes deaths were in the 40-44 age group, and type 2 diabetes peaked in those over 70. BAPC predicted declining diabetes (type 1 and type 2) mortality burden in China and globally over the next 10 years.
Conclusions: Type 2 diabetes mortality remained high in China and globally despite decreasing type 1 diabetes mortality over 30 years. Predictions suggest a gradual decrease in diabetes mortality over the next decade, highlighting the need for continued focus on type 2 diabetes prevention and treatment.
Keywords: China; Diabetes; Mortality rate.
© 2024 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Figures




Similar articles
-
Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.Clin Rheumatol. 2024 Sep;43(9):2799-2806. doi: 10.1007/s10067-024-07083-3. Epub 2024 Jul 29. Clin Rheumatol. 2024. PMID: 39073512
-
Thyroid cancer trends in China and its comparative analysis with G20 countries: Projections for 2020-2040.J Glob Health. 2024 Jun 14;14:04131. doi: 10.7189/jogh.14.04131. J Glob Health. 2024. PMID: 38873786 Free PMC article.
-
Disease burden and related risk factors of esophageal cancer in China and globally from 1990 to 2021, with forecast to 2035: An analysis and comparison.Tob Induc Dis. 2024 Aug 1;22. doi: 10.18332/tid/191389. eCollection 2024. Tob Induc Dis. 2024. PMID: 39091891 Free PMC article.
-
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019.Autoimmun Rev. 2023 Nov;22(11):103450. doi: 10.1016/j.autrev.2023.103450. Epub 2023 Sep 21. Autoimmun Rev. 2023. PMID: 37741529 Review.
-
Trends of hypertensive heart disease prevalence and mortality in the United States between the period 1990-2019, Global burden of disease database.Curr Probl Cardiol. 2024 Jul;49(7):102621. doi: 10.1016/j.cpcardiol.2024.102621. Epub 2024 May 6. Curr Probl Cardiol. 2024. PMID: 38718934 Review.
Cited by
-
The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats.Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3977-3984. doi: 10.1007/s00210-024-03517-6. Epub 2024 Oct 9. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39382680
-
Identification of risk factors for diabetes in Chinese middle-aged and elderly adults.Sci Rep. 2025 Apr 12;15(1):12550. doi: 10.1038/s41598-025-95813-1. Sci Rep. 2025. PMID: 40221523 Free PMC article.
-
Recent updates to understand the heterogeneity of type 2 diabetes mellitus.J Diabetes Investig. 2025 Apr;16(4):578-580. doi: 10.1111/jdi.70001. Epub 2025 Feb 1. J Diabetes Investig. 2025. PMID: 39891534 Free PMC article.
-
Diabetes Mellitus, a Leading Comorbidity in COVID-19: an Insight on Pathophysiology, Molecular Interactions, and Comprehensive Management.Curr Microbiol. 2025 Jul 16;82(9):388. doi: 10.1007/s00284-025-04369-w. Curr Microbiol. 2025. PMID: 40668418 Review.
-
Global trends and burdens of neglected tropical diseases and malaria from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021.BMC Public Health. 2025 Apr 7;25(1):1307. doi: 10.1186/s12889-025-22477-x. BMC Public Health. 2025. PMID: 40197173 Free PMC article.
References
-
- American Diabetes Association Professional Practice Committee . 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes‐2022. Diabetes Care 2022; 45: S17–S38. - PubMed
-
- Centers for Disease Control and Prevention . What is diabetes? 2023. Available from: https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed December 6, 2023.
-
- World Health Organization . Global action plan for the prevention and control of noncommunicable diseases 2013–2020. 2013.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical